Loading viewer...
investor_presentation
Format: PDF investor_presentation
Preliminary key figures 2017 and January renewals 6 February 2018 Jörg SchneiderImage: Getty Images/ fStop
Preliminary key figures 2017 and January renewals
Jörg SchneiderImage: Getty Images/ fStopDividend stable at €8.60 per share1, despite natcat losses –
Price and volume increase in January renewals
Preliminary key figures 2017 and January renewalsMunich Re (Group) –Financial highlights 2017
2Munich Re (Group) –2017 (Q4 2017)
Solid investment return, attrition of
running yield decelerating –
Reinvestment yield at 1.9% in Q4
Shareholders' equity
(+1.5% vs. 30.9., –11.3% vs. 31.12.16)
Strong capitalisation is basis for high
pay-outs –SII ratio almost stable2at
~240%3HGB result (German GAAP )
Release ofequalisation reserve in
fireandaviation –Distributable
earnings largely unchangedJanuary Renewals
Premium increase : 19.0%
Price increase : ~0.8%
1 Subject to approval of Supervisory Board and AGM. 2 Based on comparable calculation method vs. 31.12.2016 (242%).
3 Indication, after deduction of potential capital measures of €2.7bn in line with previous years’ capital management practices.Net result
Reinsurance result of €120m affected
by heavy natcat claims, pleasing
ERGO result of €273m –
Tax income offsets FX lossesOperating result
Technical result including fee income
in Reinsurance Life and Health of
€428m close to original guidance –
Good technical profitability at ERGOInvestment result Munich Re (Group)
Preliminary key figures 2017 and January renewals 3Highlights €m Q42017 2017 2016
Regular income 1,557 6,438 6,663
Preview truncated — download the full document for the complete content.
investor_presentation
49 Pages
investor_presentation
39 Pages
Teva Pharmaceutical Industries
investor_presentation
BeiGene